Amicus Therapeutics Inc. (FOLD)
7.95
-0.21 (-2.57%)
At close: Apr 01, 2025, 3:59 PM
8.05
1.34%
After-hours: Apr 01, 2025, 07:41 PM EDT
Amicus Therapeutics Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY03 |
| Cash & Equivalents | 213.75M | 246.99M | 148.81M | 245.2M | 163.24M | 142.84M | 79.75M | 49.06M | 187.03M | 69.48M | 24.07M | 43.64M | 33.97M | 25.67M | 29.57M | 19.34M | 28.07M | 44.19M | 12.13M | 6.45M | n/a |
| Short-Term Investments | 36.19M | 39.21M | 144.78M | 237.3M | 320.03M | 309.9M | 424.4M | 309.5M | 143.32M | 144.55M | 127.6M | 38.36M | 65.15M | 30.03M | 77.87M | 58.88M | 93.05M | 117.34M | 42.57M | 17.97M | n/a |
| Long-Term Investments | n/a | n/a | 4.3M | -4.93M | -4.9M | -5.05M | -6.46M | -6.46M | -173.77M | n/a | 17.46M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 13.64M | 18.55M | 10M | 24.43M | 19.09M | 28.32M | 6.68M | 5.2M | 2.47M | 1.11M | 502K | 552K | 442K | 709K | 267K | 485K | 267K | 267K | 267.34K | 531.74K | n/a |
| Receivables | 101.1M | 87.63M | 66.2M | 52.67M | 46.92M | 33.28M | 21.96M | 9.46M | 1.3M | n/a | n/a | 1.08M | 3.23M | 5.04M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Inventory | 118.78M | 59.7M | 23.82M | 26.82M | 19.56M | 14.04M | 8.39M | 4.62M | 3.42M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 34.91M | 49.53M | 40.21M | 34.85M | 29.72M | 20.01M | 16.59M | 19.32M | 4.99M | 2.57M | 2.9M | n/a | 2.27M | n/a | 2.24M | 2.26M | 2.46M | 1.51M | n/a | n/a | n/a |
| Total Current Assets | 504.74M | 483.06M | 423.82M | 596.83M | 579.47M | 520.07M | 551.1M | 391.96M | 340.06M | 216.6M | 154.58M | 88.28M | 104.62M | 66.65M | 109.68M | 80.49M | 123.59M | 163.04M | 55.02M | 24.86M | n/a |
| Property-Plant & Equipment | 51.66M | 57.98M | 60.31M | 63.08M | 67.16M | 81.02M | 11.38M | 9.06M | 9.82M | 6.18M | 2.81M | 4.12M | 5.03M | 2.44M | 2.6M | 4.4M | 4.92M | 3.79M | 4.36M | 3.28M | n/a |
| Goodwill & Intangibles | 215M | 218.29M | 220.8M | 220.8M | 220.8M | 220.8M | 220.8M | 220.8M | 684.5M | 684.5M | 34.61M | 34.61M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 280.3M | 294.82M | 300.35M | 308.31M | 307.05M | 330.13M | 238.85M | 235.06M | 696.78M | 691.78M | 55.39M | 39.28M | 5.47M | 3.15M | 2.87M | 4.88M | 5.19M | 4.06M | 4.63M | 3.81M | n/a |
| Total Assets | 785.03M | 777.88M | 724.17M | 905.14M | 886.52M | 850.21M | 789.95M | 627.02M | 1.04B | 908.38M | 209.97M | 127.56M | 110.09M | 69.8M | 112.55M | 85.37M | 128.77M | 167.1M | 59.65M | 28.67M | 501K |
| Account Payables | 12.95M | 15.12M | 15.41M | 21.51M | 17.06M | 21.72M | 6.61M | 7.87M | 12.9M | 16.48M | 5.87M | 2.15M | 2.12M | 2.58M | n/a | n/a | 1.99M | 530K | 1.2M | 906.23K | n/a |
| Deferred Revenue | n/a | n/a | 4.94M | n/a | 1.5M | 1.25M | 5.5M | 7.75M | 69.4M | n/a | -10.47M | n/a | -6.73M | 8.5M | 6.64M | n/a | 3.71M | 3.8M | n/a | n/a | n/a |
| Short-Term Debt | 8.46M | n/a | 8.55M | 7.41M | 6.87M | 7.19M | n/a | n/a | n/a | n/a | 3.84M | 299K | 398K | 1.04M | 1.25M | 1.25M | 877K | 1.53M | 1.31M | 279.26K | n/a |
| Other Current Liabilities | 127.3M | 93.51M | 74.86M | 79.23M | 64.67M | 53.06M | 32.06M | 30.82M | 23.8M | 50.94M | 5.42M | 3.23M | 2.5M | 12.47M | 8.29M | 3.24M | 5.93M | 7.66M | 6.47M | 1.39M | n/a |
| Total Current Liabilities | 148.7M | 167.69M | 139.02M | 145.97M | 129.68M | 128.81M | 86.13M | 70.04M | 110.96M | 73.62M | 20.18M | 10.46M | 9.24M | 19.26M | 16.22M | 11.19M | 13.38M | 15.79M | 10.21M | 2.59M | n/a |
| Long-Term Debt | 435.19M | 387.86M | 443.57M | 432.72M | 434.86M | 149.5M | 321.74M | 164.17M | 154.46M | 41.6M | 10.51M | 14.17M | 299K | n/a | 1.04M | 2.3M | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | 7.1M | 13.28M | -37.98M | -29.22M | -14.89M | 36.88M | 32.71M | 33.5M | 237.5M | 269.11M | 47.91M | 47.99M | 31.33M | 1.95M | 4.71M | n/a | n/a | n/a | 124.7M | 61.17M | n/a |
| Total Long-Term Liabilities | 442.29M | 450.02M | 462.1M | 451.8M | 470.46M | 244.97M | 360.91M | 204.13M | 565.74M | 486.93M | 67.6M | 71.35M | 31.63M | 20.95M | 31.39M | 2.34M | 44.35M | 48.01M | 126.95M | 61.91M | n/a |
| Total Liabilities | 590.99M | 617.71M | 601.12M | 597.77M | 600.14M | 373.78M | 447.04M | 274.17M | 676.69M | 560.55M | 87.79M | 81.81M | 40.87M | 40.2M | 47.62M | 13.54M | 57.73M | 63.8M | 137.16M | 64.5M | 5.78M |
| Total Debt | 443.64M | 445.06M | 452.12M | 440.13M | 441.73M | 210.22M | 321.74M | 164.47M | 154.46M | 41.6M | 14.35M | 14.47M | 697K | 1.04M | 2.34M | 3.9M | 1.19M | 2.72M | 3.56M | 1.01M | n/a |
| Common Stock | 2.94M | 2.92M | 2.81M | 2.81M | 2.65M | 2.6M | 1.94M | 1.72M | 1.48M | 1.31M | 1.01M | 679K | 556K | 407K | 406K | 287K | 287K | 285K | 70.29K | 40.35K | n/a |
| Retained Earnings | -2.74B | -2.68B | -2.53B | -2.3B | -2.05B | -1.77B | -1.41B | -1.06B | -779.61M | -579.57M | -447.45M | -378.52M | -318.89M | -270.1M | -225.69M | -170.76M | -164.19M | -124.83M | -83.67M | -37.32M | -8.5M |
| Comprehensive Income | 5.09M | 5.24M | -12.11M | 4.98M | 8.23M | 2.83M | 68K | -2.1M | 2.05M | -115K | -132K | 1K | 14K | 4K | -28K | 43K | 533K | 408K | 14.75K | -2.56M | n/a |
| Shareholders Equity | 194.04M | 160.17M | 123.05M | 307.37M | 286.38M | 476.43M | 342.91M | 352.85M | 360.15M | 347.83M | 122.18M | 45.75M | 69.22M | 29.59M | 64.93M | 71.83M | 71.04M | 103.3M | -77.52M | -35.83M | -5.28M |
| Total Investments | 36.19M | 39.21M | 144.78M | 237.3M | 320.03M | 309.9M | 424.4M | 309.5M | 143.32M | 144.55M | 145.06M | 38.36M | 65.15M | 30.03M | 77.87M | 58.88M | 93.05M | 117.34M | 42.57M | 17.97M | n/a |